Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor
Authors:
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 140 (2) , 523-529
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Differential Effects of Tamoxifen and Analogs with Nonbasic Side Chains on Cell Proliferationin VitroEndocrinology, 1985
- Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7British Journal of Cancer, 1984
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Metabolism of clomiphene in the ratBiochemical Pharmacology, 1983
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- Calmodulin and the cell cycle: Involvement in regulation of cell-cycle progressionCell, 1982
- Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptors.Journal of Biological Chemistry, 1981